The National Institute on Aging (NIA) is offering a limited competition grant to sustain the NIA Genome Center for Alzheimer’s Disease (GCAD) dedicated to supporting the Alzheimer’s Disease Sequencing Project (ADSP). The grant aims to continue quality control, data harmonization, and meta-analysis for ADSP activities. The Center will play a crucial role in multidisciplinary efforts for Alzheimer’s Disease and AD Related Dementias (ADRD). By serving as a national resource, the Center focuses on identifying therapeutic avenues and disease prevention strategies in alignment with NIA’s programmatic goals. Application deadline: September 25, 2022.
Opportunity ID: 316343
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-19-288 |
| Funding Opportunity Title: | Limited Competition: NIA Genome Center for Alzheimer’s Disease (U54 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.866 — Aging Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | May 23, 2019 |
| Last Updated Date: | May 23, 2019 |
| Original Closing Date for Applications: | Sep 25, 2022 |
| Current Closing Date for Applications: | Sep 25, 2022 |
| Archive Date: | Oct 31, 2022 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Public and State controlled institutions of higher education For profit organizations other than small businesses Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Special district governments Small businesses State governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education County governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) invites applications to continue the operations of the NIA Genome Center for Alzheimer’s Disease (GCAD) to facilitate and support the Alzheimer’s Disease Sequencing Project (ADSP) activities. GCAD will serve as the focal point for all phases of ADSP quality control checking, data harmonization, and meta-analysis. The FOA is intended to support a major component of the full range of analysis for the ADSP. The spectrum of the Center’s activities comprises a multidisciplinary attack on Alzheimer’s Disease (AD) and AD Related Dementias (ADRD) in keeping with NIA’s programmatic needs. The Center will serve as a national resource for the specific purpose of identifying potential avenues for therapeutic approaches and prevention of the disease. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-19-288.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 316343 Full Announcement-PAR-19-288 -> PAR-19-288-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00251304 | Aug 25, 2019 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00258928 | Aug 25, 2019 | Jan 24, 2022 | View | |
| FORMS-G | Use for due dates on or after January 25, 2022 | PKG00269617 | Aug 25, 2019 | Sep 25, 2022 | View |
Package 1
Mandatory forms
316343 RR_SF424_2_0-2.0.pdf
316343 PHS398_CoverPageSupplement_4_0-4.0.pdf
316343 RR_OtherProjectInfo_1_4-1.4.pdf
316343 PerformanceSite_2_0-2.0.pdf
316343 RR_KeyPersonExpanded_2_0-2.0.pdf
316343 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
316343 PHS_Additional_IndirectCosts-1.0.pdf
316343 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
316343 RR_SF424_2_0-2.0.pdf
316343 PHS398_CoverPageSupplement_5_0-5.0.pdf
316343 RR_OtherProjectInfo_1_4-1.4.pdf
316343 PerformanceSite_2_0-2.0.pdf
316343 RR_KeyPersonExpanded_2_0-2.0.pdf
316343 PHS398_ResearchPlan_4_0-4.0.pdf
316343 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
316343 PHS_Additional_IndirectCosts-1.0.pdf
316343 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
316343 RR_SF424_5_0-5.0.pdf
316343 PHS398_CoverPageSupplement_5_0-5.0.pdf
316343 RR_OtherProjectInfo_1_4-1.4.pdf
316343 PerformanceSite_4_0-4.0.pdf
316343 RR_KeyPersonExpanded_4_0-4.0.pdf
316343 PHS398_ResearchPlan_4_0-4.0.pdf
316343 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
316343 PHS_Additional_IndirectCosts_2_0-2.0.pdf
316343 PHS_AssignmentRequestForm_3_0-3.0.pdf